Nurturing Excellence, Strengthening Talent NEST 2.0

Nurturing Excellence, Strengthening Talent NEST 2.0

About Nurturing Excellence, Strengthening Talent NEST 2.0

About Novartis Development India Hub

The Novartis Global Development division is responsible for advancing our pipeline of investigational medicines, to bring transformative new treatment options to patients with serious diseases. It leads the clinical development of potential new medicines, running large clinical trials and generating evidence that turns molecules to medicines. The key hubs of this division are in Switzerland (Basel), the USA (East Hanover); and India (Hyderabad and Mumbai). The Development hub in India works on supporting global development projects to generate evidence and convert molecules to medicines.

The India hub has evolved over more than 20 years and today sees three vibrant state-of-the-art centres across two cities, Hyderabad – at the Novartis Corporate Center (NOCC) and Genome Valley, and a recent one in Mumbai. Today, the India hub is an important base to support the development journey of many breakthrough medicines across all therapy areas (cardiovascular renal metabolic, oncology, immunology, neuroscience). The India center supports all global functions including Global Clinical Operations, Technical R&D, Patient Safety and Pharmacovigilance, Regulatory Affairs, Advanced Quantitative Science, to name a few. The vast footprint of the Development division in India (~2,800 employees) is instrumental in supporting the company’s long-term growth and delivering on its purpose to improve and extend people’s lives.

For over 15 years, Novartis Technical R&D (TRD) has been increasing its footprint in Genome Valley, Hyderabad and currently 300+ scientists including Masters, PhDs and post doctorates are supporting the pharmaceutical development of new chemical entities. The Indian scientists are providing support in the development of many chemical entities aligned with our focus therapies. The India hub provides impetus to bright leaders and also deepens its focus on drug development work.

Eligibility:

* Participants can register in teams comprising 1 to 4 members.

* For teams advancing to Round 2, it is mandatory to have a faculty mentor affiliated with the same institute or any other who will guide them in developing a working solution for the given use cases. The total team size, including the faculty mentor, must not exceed five members.

* All final and pre-final year students are eligible to participate in this engagement.

* Cross-organization teams are allowed.

* Cross-specialization teams are allowed.

* A participant cannot be a member of more than one team.

Any deviation from the aforementioned rules will result in the immediate disqualification of the entire team.

For more details refer the Website

Other Awards and Competitions In India